Quantitative assessment of WT1 expression by real time quantitative PCR in acute lymphoblastic leukemia (ALL) as a prognostic marker and monitor of minimal residual disease (MRD) - Egyptian Knowledge Bank

43480

Quantitative assessment of WT1 expression by real time quantitative PCR in acute lymphoblastic leukemia (ALL) as a prognostic marker and monitor of minimal residual disease (MRD)

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

The usefulness of quantitative assessment of Wilms' tumor gene 1 (WT1) expression by real-time PCR during minimal residual disease monitoring of acute myeloid leukemia

Thesis

Assessment of minimal residual disease in acute leukemia

Thesis

Cyclin D1 in acute lymphoblastic leukemia: A prognostic marker

Thesis

Prognostic significance of molecular markers in acute myeloid leukemia

Thesis

The clinical significance of ROR-1 gene expression in children with acute lymphoblastic leukemia

Thesis

Detection of BCL-XL and BCL-XS in acute lymphoblastic leukemia

Thesis

CEBPA expression levels as a prognostic marker in acute myelogenous leukemia

Thesis

Role of molecular techniques as a tool in hematological malignancies as regards diagnosis, prognosis and follow up for minimal residual disease

Thesis

Quantitative expression of recombinase activatinggene (RAG1 & RAG2) in lymphoid malignancy byreal time PCR

Thesis

The use of monoclonal IGH gene rearrangement for detection of minimal residual disease and monitoring tumor cell purge by long-term culture in acute lymphoblastic leukemia